Table 1.
Patient Characteristics
| Brazil (n=131) | Chile (n=71) | India (n=44) | Jordan (n=182) | U.S (n=300) | Total (n=728) | |
|---|---|---|---|---|---|---|
| Age, mean (range) | 58 (26–81) | 60 (28–85) | 51 (24–73) | 55 (19–84) | 58 (21–85) | 57 (19–85) |
| Female, No. (%) | 61 (46.6) | 44 (62) | 26 (59.1) | 86(47.3) | 144(48) | 361(49.6) |
| Race, No. (%) | ||||||
| Non-Hispanic White | 0 | 0 | 0 | 0 | 229 (76.3) | 229 (31.5) |
| Black | 0 | 0 | 0 | 0 | 37 (12.3) | 37 (5.1) |
| Hispanic | 131 (100) | 71 (100) | 0 | 0 | 22 (7.3) | 224 (30.8) |
| Asian | 0 | 0 | 44 (100) | 0 | 11 (3.7) | 55 (7.6) |
| Jordanian | 0 | 0 | 0 | 182 (100) | 0 | 182 (25) |
| Other | 0 | 0 | 0 | 0 | 1 (0.3) | 1 (0.1) |
| Marital Status, No. (%) | ||||||
| Single | 16 (12.2) | 16 (22.5) | 2 (4.5) | 19 (10.4) | 45 (15.1) | 98 (13.5) |
| Married | 85 (64.9) | 40 (56.3) | 38 (86.4) | 139 (76.4) | 200 (67.1) | 502 (69.1) |
| Divorced | 30 (22.9) | 15 (21.1) | 4 (9.1) | 24 (13.2) | 53 (17.8) | 126 (17.4) |
| Education, No. (%) | ||||||
| Illiterate or high school or less | 114 (87) | 21 (29.6) | 38 (86.3) | 111 (61) | 77 (25.7) | 361 (49.6) |
| Some college up to bachelor’s | 16 (12.2) | 47 (66.2) | 5 (11.4) | 58 (31.9) | 173 (57.7) | 299 (41.1) |
| Advanced degree | 1 (0.8) | 3 (4.2) | 1 (2.3) | 13 (7.1) | 50 (16.7) | 68 (9.3) |
| Cancer, No. (%) | ||||||
| Breast | 26 (19.8) | 11 (15.5) | 6 (13.6) | 40 (22) | 48 (16) | 131 (18) |
| Gastrointestinal | 25 (19.1) | 26 (36.6) | 7 (15.9) | 31 (17) | 68 (22.7) | 157 (21.6) |
| Genitourinary | 30 (22.9) | 6 (8.5) | 2 (4.5) | 14 (7.7) | 25 (8.3) | 77 (10.6) |
| Gynecologic | 16 (12.2) | 6 (8.5) | 15 (34.1) | 7 (3.8) | 20 (6.7) | 64 (8.8) |
| Head and neck | 5 (3.8) | 0 | 7 (15.9) | 18 (9.9) | 40 (13.3) | 70 (9.6) |
| Hematologic | 4 (3.1) | 8 (11.3) | 1 (2.3) | 10 (5.5) | 8 (2.7) | 31 (4.3) |
| Non-small cell lung | 0 | 0 | 0 | 0 | 1 (0.3) | 1 (0.1) |
| Other | 10 (7.6) | 6 (8.5) | 3 (6.8) | 25 (13.7) | 39 (13) | 83 (11.4) |
| Respiratory | 15 (11.5) | 8 (11.3) | 3 (6.8) | 37 (20.3) | 51 (17) | 114 (15.7) |
| Cancer Stage, No. (%) | ||||||
| Advanced | 0 | 0 | 0 | 8 (4.4) | 8 (2.7) | 16 (2.2) |
| Locally Advanced | 23 (17.6) | 8 (11.3) | 6 (13.6) | 9 (4.9) | 34 (11.3) | 80 (11) |
| Metastatic | 108 (82.4) | 63 (88.7) | 38 (86.4) | 165 (90.7) | 258 (86) | 632 (86.8) |
| CAGE positive, No. (%) | 38 (29) | 6 (8) | 6 (14) | 7 (4) | 43 (14) | 100 (14) |
| MDAS, mean (SD) | 2.5 (1.5) | 2.4 (1.9) | 2.3 (1.1) | 2.8 (2) | 1.2 (1.3) | 2 (1.7) |
| KPS baseline, mean (SD) | 71 (13) | 78 (13) | 77 (6) | 68 (14) | --† | -- |
| KPS follow-up, mean (SD) | 70 (13) | 75 (14) | 74 (5) | 66 (15) | 69 (13) | 69 (13) |
†
No KPS data collected from U.S. initial visit